BioRestorative prices $5M stock offering [Seeking Alpha]
BioRestorative Therapies, Inc. (BRTX)
NASDAQ:AMEX Investor Relations:
biorestorative.com/content/investor-relations
Company Research
Source: Seeking Alpha
Net proceeds will fund BRTX-100 clinical trials for disc/spine disease, ThermoStem pre-clinical R&D for metabolic disorders, biocosmeceuticals platform expansion, and general working capital. Gross proceeds are ~$5M before fees. The closing of the offering is expected to occur on or about February 13, 2026. The stock price dropped 4.4% on Thursday during pre-market trade. More on BioRestorative Therapies Seeking Alpha's Quant Rating on BioRestorative Therapies Historical earnings data for BioRestorative Therapies Financial information for BioRestorative Therapies Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
BRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BRTX alerts
High impacting BioRestorative Therapies, Inc. news events
Weekly update
A roundup of the hottest topics
BRTX
News
- BioRestorative Announces Pricing of $5.0 Million Public OfferingGlobeNewswire
- BioRestorative Announces Positive Outcome from Type B Meeting with FDAGlobeNewswire
- BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc DiseaseGlobeNewswire
- ?????????????????????????????2035????18?6170??????49?5700???????????????(CAGR)10.29%???????????? [CNET News]CNET News
- Biorestorative Therapies (NASDAQ:BRTX) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
BRTX
Sec Filings
- 2/12/26 - Form EFFECT
- 2/10/26 - Form S-1/A
- 2/9/26 - Form S-1
- BRTX's page on the SEC website